Abstract
BackgroundMetastatic and recurrent/refractory Ewing sarcoma (ES) has a dismal prognosis,1 largely secondary to therapy resistance within the tumor microenvironment.2 ES have heightened natural killer (NK) cell sensitivity,3 and increased abundance...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
